Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$9.63B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  NXL
Nexalin Technology
NXL
52 / 100
Penny Stock
$1.63arrow_drop_up13.98%$0.20

Performance History

Stocklytics logo
Key Stats
Open$1.61
Prev. Close$1.62
EPS-0.63
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap10634280.00
PE Ratio-
LOWHIGH
Day Range1.42
1.61
52 Week Range0.25
3.40
Ratios
P/B Ratio5.31
Revenue-
Operating M. %-7,910.37%
Earnings$0.00
Earnings Growth %-173.81%
EBITDA Margin %-
ROE %-107.05%
EPS-0.63

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

52vs 54. Market Avg.

All Score 52 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

NXLMARKET
Value3340
Quality4140
Ownership1017
Growth5345
Dividends-38
check_circle

Nexalin Technology 's Price growth average in the last 3 years of 96.97% is great compared to market average of 5.62%. This indicates NXL could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$732.20
24H (%)arrow_drop_down1.80%
24H ($)-$13.48
MARKET CAP$695.32B
PRICE$487.29
24H (%)arrow_drop_up0.23%
24H ($)$1.12
MARKET CAP$452.88B
PRICE$148.53
24H (%)arrow_drop_down0.68%
24H ($)-$1.03
MARKET CAP$359.34B
PRICE$127.00
24H (%)arrow_drop_up0.09%
24H ($)$0.12
MARKET CAP$321.39B

About Nexalin Technology (NXL)

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Mark White
Headquarters
Houston
Employees
6
Exchange
NASDAQ
add Nexalin Technology  to watchlist

Keep an eye on Nexalin Technology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Nexalin Technology 's (NXL) price per share?

The current price per share for Nexalin Technology (NXL) is $1.42. The stock has seen a price change of -$0.2 recently, indicating a -12.37% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Nexalin Technology (NXL)?

For Nexalin Technology (NXL), the 52-week high is $3.4, which is 138.76% from the current price. The 52-week low is $0.25, the current price is 462.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Nexalin Technology (NXL) a growth stock?

Nexalin Technology (NXL) has shown an average price growth of 96.97% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nexalin Technology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Nexalin Technology (NXL) stock price performance year to date (YTD)?

As of the latest data, Nexalin Technology (NXL) has a year-to-date price change of 257.52%. Over the past month, the stock has experienced a price change of 184.8%. Over the last three months, the change has been 286.96%. Over the past six months, the figure is 399.65%.

help
Is Nexalin Technology (NXL) a profitable company?

Nexalin Technology (NXL) has a net income of -$4.65M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.91K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$5.7M. Furthermore, the EBITDA is -$5.69M.

help
What is the market capitalization of Nexalin Technology (NXL)?

Nexalin Technology (NXL) has a market capitalization of $10.63M. The average daily trading volume is 259.61K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.